See also this year's filing and all EDGAR filings for this company.
PDF Report 0001596062_2018_Q_BioMed_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.019078694481382396, 'aggregate_val': 14541667, 'exp_sum': 14269425, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 9271804, 'ResearchAndDevelopmentExpense': 3099971, 'remainder_Expenses': 1897650}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001596062')"} |
Graph
Absolute values for 0001596062, Q BioMed Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 827,283 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 471,039 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 9,271,804 |
| 9 | ResearchAndDevelopmentExpense | 3,099,971 |
| 10 | remainder_Expenses | 2,169,892 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 827,283 |
| 1 | Liabilities | 471,039 |
| 2 | Expenses | 14,541,667 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 356,244 |
| 5 | NetIncome | -14,541,667 |
| 6 | ComprehensiveNetIncome | -14,541,667 |
| 7 | BaseVar | 7,919,994 |
| 8 | EconomicCapitalRatio | -21.5 |
Edgar->Model Mapping
Feature Distribution
Change over Time
